Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Children's Oncology Group
Children's Oncology Group
Eastern Cooperative Oncology Group
SWOG Cancer Research Network
Children's Oncology Group
Children's Oncology Group
SWOG Cancer Research Network
Canadian Cancer Trials Group
SWOG Cancer Research Network
AIDS Malignancy Consortium
SWOG Cancer Research Network